Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0432222 (
SEM
)
47,337
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The classic biomimetic apatite coating process can be accelerated by first immersing substrates into concentrated simulated body fluid, 5x SBF (
SBF1
), at 37 degrees C, to form an initial coating of precursor apatite spheres, and subsequently transferring to a second 5x SBF (SBF2) solution which is devoid of crystal growth inhibitors to promote phase transformation of
SBF1
-derived precursor apatite spheres into final crystalline apatite plates. Since
SBF1
governs the formation kinetics and composition of the initial precursor spheres, we hypothesized that the pH of the
SBF1
solution will also influence the final structure of the SBF2-derived crystalline apatite. To test this hypothesis, polystyrene substrates were immersed into
SBF1
with different pH (5.8 or 6.5), and then immersed into the identical SBF2 (pH=6.0). The resultant apatites exhibited similar 2 theta XRD peaks; FTIR spectra in terms of hydroxyl, phosphate and carbonate groups; and Ca/P atomic ratio (1.42 for
SBF1
(5.8) apatite; 1.48 for
SBF1
(6.5) apatite).
SEM
, TEM and electron diffraction show that while
SBF1
(6.5) (pH 6.5) precursor spheres transform into larger, single crystals plates,
SBF1
(5.8) (pH 5.8) precursor spheres developed minute, polycrystalline plate-like structures over predominantly spherical precursor substrate.
...
PMID:The effect of pH on the structural evolution of accelerated biomimetic apatite. 1511 Apr 83